SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is experiencing explosive momentum, driven by a massive short squeeze following a new strategic deal, with many comparing its parabolic ascent to legendary past runners. The community is buzzing with excitement and disbelief over the rapid gains, focusing on its low float and high short interest as key factors fueling the dramatic price action.

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is actively trending amid widespread community excitement, primarily driven by persistent buzz around potential new major exchange listings and a noticeable surge in trading volume. The community emphasizes its core utility as a Layer 1 network, featuring an AI-integrated exchange and cross-chain bridging technology, with many anticipating substantial "altseason" gains. Discussions frequently highlight its perceived undervaluation and the significant slowing of token dilution as key catalysts for future appreciation within the evolving crypto landscape.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci Corp

Cel-Sci Corp is trending due to intense community speculation regarding an imminent Breakthrough Medicine Designation from the Saudi Food and Drug Authority (SFDA) for its Multikine treatment. Optimists cite company communications about addressing scientific inquiries and supporting Saudi Arabia's Vision 2030 goals, alongside recent insider buying. Conversely, a vocal skeptical contingent points to historical trial outcomes and ongoing equity offerings, raising concerns about potential dilution amidst the prolonged wait for a definitive regulatory decision.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is garnering significant attention as its strategic bank acquisition positions it to transition into a regulated financial institution, a move the community hails as a game-changer for its integrated payment infrastructure. Enthusiastic discussions highlight Keeta's high transaction speed and built-in compliance, projecting its potential to redefine global finance through native fiat rails and real-world asset tokenization. The strong backing from a former Google CEO further fuels optimism about its long-term impact on compliant cross-chain payments.

Trump For President

TRUMP CRYPTO is actively trending amid intense community discussion, largely driven by political developments surrounding Venezuela and broader speculation about global influence. While supporters link the coin's potential for significant gains to the former president's ongoing political actions, many others express strong skepticism, highlighting the asset's volatility and lack of intrinsic value.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana (CVNA) is a focal point of intense market debate, propelled by recent analyst upgrades to significantly higher price targets and ongoing discussions around a class action lawsuit related to alleged stock manipulation. Community discussion is sharply split, with many labeling the company a "scam" or "fraudulent" due to its high valuation and subprime auto loan exposure, while bullish traders highlight its resilience, "short squeeze" dynamics, and ability to defy fundamental skepticism. This ongoing controversy underscores broader market concerns about speculative valuations and institutional influence on price action.

Alchemy Pay

Alchemy Pay (ACH) is generating buzz due to its ongoing expansion of fiat-to-crypto payment gateways, securing multiple U.S. Money Transmitter Licenses, and numerous partnerships enhancing its global on/off-ramp capabilities. The community is particularly focused on its transition to a Layer-1/Layer-2 blockchain with a stablecoin-focused whitepaper, viewing these architectural upgrades and increased token utility as key drivers for potential appreciation, despite some market skepticism.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals is trending following the completion of its Astria Therapeutics acquisition, which significantly expands its hereditary angioedema (HAE) pipeline with the late-stage drug navenibart. The community is actively discussing the strategic implications, including favorable new financing terms and a recent ORLADEYO price increase, while debating preliminary guidance that some view as conservative sandbagging by new leadership. Amidst strong revenue growth and expectations for profitability, many express frustration over the stock's perceived undervaluation and ongoing market dynamics.

NeoVolta, Inc. engages in the designing, manufacturing, and developing of residential energy storage systems (ESS). Its products include: NV14, NV24, NVPlus, NV7600, and NV16. The company was founded by Brent Willson on March 5, 2018 and is headquartered in Poway, CA.

NeoVolta Inc

NeoVolta is trending following its pivotal joint venture to establish a U.S. battery manufacturing platform, positioning it as a key player in the expanding energy storage market. This development, combined with the company's low float and notable short interest, is igniting widespread community discussion around a potential short squeeze. Investors are closely watching for sustained momentum as the company expands its presence in the burgeoning clean energy sector.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a hot topic among traders following a new manufacturing partnership aimed at bolstering production and margins, coupled with a significant private placement. The community is actively discussing the potential for a short squeeze, citing a low float and high cost to borrow, while also debating the impact of future share dilution. Anticipation for pending FDA approval for its non-invasive drug testing technology is a key factor in long-term sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

MindWalk Holdings Corp. (MindWalk, Company, we or us) (Nasdaq: HYFT), bio-native AI company today announces the appointment of industry veteran R. Scott Areglado as Chief Financial Officer (CFO...

Shares of AI-powered breast health solutions provider iCAD, Inc. (ICAD) rocketed over 67% on Wednesday morning after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.icadmed.com/about/news-events/press-releases/radnet-inc-to-acquire-icad-inc-to-accelerate-ai-powered-early-detection-and-diagnosis-of-breast-cancer/">said</a> it entered a definitive merger agreement with RadNet (RDNT).Diagnostic imaging services provider RadNet will acquire iCAD in an all-stock transaction where iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger.Based upon RadNet’s closing price on Monday, this represents a transaction value of approximately $103 million, or approximately $3.61 per share of iCAD common stock on a fully diluted basis and an approximately 98% premium to iCAD stockholders based on iCAD’s closing stock price on Monday, the company said.The transaction is expected to close in the second or third quarter of 2025, subject to approval by iCAD stockholders. It is expected to add to RadNet’s wholly-owned unit DeepHealth, an installed base of over 1,500 healthcare provider locations across over 50 countries.RadNet CEO Howard Berger said that iCAD’s ProFound Breast Health Suite and RadNet’s DeepHealth AI-powered breast screening solutions together have the power to improve patient diagnosis of breast cancer.“With over 1,500 healthcare provider locations, facilitating over eight million annual mammograms in 50 countries, iCAD’s installed base and strong sales, engineering, and marketing capabilities will provide us with immediate broad and valuable customer relationships and commercialization capabilities that can accelerate our existing DeepHealth objectives,” he said.RadNet stock fell by about 7% on Wednesday.On Stocktwits, retail sentiment around iCAD rose from ‘bearish’ to ‘extremely bullish’ over the past 24 hours while message volume jumped from ‘extremely low’ to ‘extremely high’.<figure class="image"><img style="aspect-ratio:652/146;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_16_at_10_23_43_AM_png_7dae918bc5.webp" alt="ICAD's Sentiment Meter and Message Volume as of 10:20 a.m. ET on April 16, 2025 | Source: Stocktwits" width="652" height="146"><figcaption>ICAD's Sentiment Meter and Message Volume as of 10:20 a.m. ET on April 16, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/ICAD">ICAD stock</a> is up by over 62% year-to-date and has more than doubled over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/travelers-q1-2025-earnings/chQPN6URbOo">Travelers Q1 2025 Earnings Beat Wall Street Estimates Despite $2.26 Billion California Wildfires Losses, Revenue Falls Short Of Estimates</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

iCAD Stock Rockets On Merger Announcement With RadNet: Retail’s Elated

Diagnostic imaging services provider RadNet will acquire iCAD in an all stock transaction where iCAD stockholders will receive 0.0677 shares of RadNet common stock for each share of iCAD common stock they hold at the closing of the merger.

Equity

iCAD, Inc. is a global medical technology company, which engages in the provision of cancer detection and therapy solutions. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and workflow products. The Cancer Therapy segment relates to radiation therapy products. The company was founded in 1984 and is headquartered in Nashua, NH.

Icad Inc

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

ICAD
Icad Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ICAD News

ICADIcad Inc